Foghorn Therapeutics Inc.
FHTX· Nasdaq
Foghorn Therapeutics Inc.
- Last sale
- Oct 1, 2026 · -17.56%
- Market cap
- $174.30M
- 59.39M shares
- Filings
- 352
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $30,909,000 | reported | |
| FY 2024 | 2024-12-31 | $22,602,000 | reported | |
| FY 2023 | 2023-12-31 | $34,155,000 | reported | |
| FY 2022 | 2022-12-31 | $19,228,000 | reported | |
| FY 2021 | 2021-12-31 | $1,319,000 | reported | |
| FY 2020 | 2020-12-31 | $430,000 | reported |
Foghorn Therapeutics Inc. · CIK 1822462 · Engraved from SEC EDGAR
